Board meeting on October 29, 2026 to approve Q2 and H1 results
Senores Pharmaceuticals has called a Board meeting on Thursday, October 29, 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Thursday, October 29, 2026
- Agenda Period
- quarter and half year ended September 30, 2026
- Trading Window Closure Start
- October 01, 2026 till 48 hours after the results are approved
What was announced
The company has informed BSE (Scrip Code 544319) and NSE (Symbol SENORES) that a meeting of its Board of Directors is scheduled to be held on Thursday, October 29, 2026.
What the board will take up
- To consider and approve the Un-audited Consolidated and Standalone Financial Results of the company for the quarter and half year ended September 30, 2026.
- To transact other business matters.
Consolidated and Standalone, in simple words
- Standalone results cover the company on its own.
- Consolidated results cover the company together with its subsidiaries and other group entities, giving the full picture of the group.
- The half year ended September 30 covers two quarters together: April to June and July to September.
Trading window
Referring to its earlier intimation dated September 24, 2026, the company said the trading window for dealing in its securities, for persons specified under its Code of Conduct (framed under SEBI's insider trading regulations), was closed from October 01, 2026 and will remain closed till 48 hours after the results are approved by the Board and submitted to the stock exchanges.
This is a restriction on designated persons covered by the Code; it is not a restriction on the company's shares being traded on the exchanges.
What to watch
- The results themselves, once approved and shared, are where the quarter's revenue, profit and other financial figures will appear.
- The board meeting date tells you when that disclosure is expected.
The announcement is a scheduling intimation, so it sets a date rather than reporting performance.
Also from Senores Pharmaceuticals
Senores Q2 FY27 earnings conference call rescheduled to 04:00 P.M. IST on October 29, 2026
23 Oct 2026
Senores Pharmaceuticals to hold Q2 & H1 FY27 earnings conference call on October 29, 2026
22 Oct 2026
Board re-appoints Managing Director and Whole-time Director for three years each
13 Oct 2026
More numbers
- Trading window opens 48 hours after results are approved48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.